CDC advisory panel backs J&J’s Covid-19 vaccine, clearing way for pause to be lifted
An expert panel on Friday recommended that the United States resume use of Johnson & Johnson’s Covid-19 vaccine, likely ending a 10-day “pause” placed on the vaccine after a small number of unusual clotting events were reported among people who had received it.
The Food and Drug Administration and the Centers for Disease Control and Prevention, which had jointly issued the pause, were expected to lift it Friday evening, on the advice of the Advisory Committee on Immunization Practices.
